FERI (Luxembourg) S.A.’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
FERI (Luxembourg) S.A.'s ABBV Position: Q3 2026 in Review
FERI (Luxembourg) S.A. increased its AbbVie (ABBV) stake by 6.9% in Q3 2026, buying an estimated $600K and bringing the position to 36,330 shares worth $9.5M. The position accounts for 1.27% of the portfolio, ranked #20.
FERI (Luxembourg) S.A. first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- FERI (Luxembourg) S.A. held 36,330 shares of AbbVie worth $9.5M as of Q3 2026.
- FERI (Luxembourg) S.A. bought 2,340 AbbVie shares in Q3 2026, an estimated $600K.
- AbbVie made up 1.27% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #20 holding.
- FERI (Luxembourg) S.A. first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
- 4,063 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.